351 related articles for article (PubMed ID: 23065427)
21. [Outcome of childhood T-cell acute lymphoblastic leukemia: a report of 99 cases].
Cai JY; Xue HL; Chen J; Shen SH; Pan C; Wang X; Zhou M; Tang YJ; Gao YJ; Wang JM; Tang JY
Zhonghua Er Ke Za Zhi; 2016 Jun; 54(6):456-60. PubMed ID: 27256235
[TBL] [Abstract][Full Text] [Related]
22. Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.
Xu X; Paxton CN; Hayashi RJ; Dunsmore KP; Winter SS; Hunger SP; Winick NJ; Carroll WL; Loh ML; Devidas M; Gross TG; Bollard CM; Perkins SL; Miles RR
Blood Adv; 2021 Jul; 5(14):2890-2900. PubMed ID: 34297047
[TBL] [Abstract][Full Text] [Related]
23. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
24. Early T-Cell Precursor Leukemia Has a Higher Risk of Induction-Related Infection among T-Cell Acute Lymphoblastic Leukemia in Adult.
Huang K; Dai M; Li Q; Liu N; Lin D; Wang Q; Zhou X; Wang Z; Gao Y; Jin H; Liu X; Liu Q; Zhou H
Mediators Inflamm; 2020; 2020():8867760. PubMed ID: 33424437
[TBL] [Abstract][Full Text] [Related]
25. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
Wood BL; Devidas M; Summers RJ; Chen Z; Asselin B; Rabin KR; Zweidler-McKay PA; Winick NJ; Borowitz MJ; Carroll WL; Raetz EA; Loh ML; Hunger SP; Dunsmore KP; Teachey DT; Winter SS
Blood; 2023 Dec; 142(24):2069-2078. PubMed ID: 37556734
[TBL] [Abstract][Full Text] [Related]
27. Early T-cell precursor leukemia/lymphoma in adults and children.
Allen A; Sireci A; Colovai A; Pinkney K; Sulis M; Bhagat G; Alobeid B
Leuk Res; 2013 Sep; 37(9):1027-34. PubMed ID: 23827350
[TBL] [Abstract][Full Text] [Related]
28. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
29. FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.
Neumann M; Coskun E; Fransecky L; Mochmann LH; Bartram I; Sartangi NF; Heesch S; Gökbuget N; Schwartz S; Brandts C; Schlee C; Haas R; Dührsen U; Griesshammer M; Döhner H; Ehninger G; Burmeister T; Blau O; Thiel E; Hoelzer D; Hofmann WK; Baldus CD
PLoS One; 2013; 8(1):e53190. PubMed ID: 23359050
[TBL] [Abstract][Full Text] [Related]
30. Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
Patrick K; Wade R; Goulden N; Mitchell C; Moorman AV; Rowntree C; Jenkinson S; Hough R; Vora A
Br J Haematol; 2014 Aug; 166(3):421-4. PubMed ID: 24708207
[TBL] [Abstract][Full Text] [Related]
31. Clinical characterization and prognosis of T cell acute lymphoblastic leukemia with high CRLF2 gene expression in children.
Wang M; Wen J; Guo Y; Shen Y; An X; Hu Y; Xiao J
PLoS One; 2019; 14(12):e0224652. PubMed ID: 31830053
[TBL] [Abstract][Full Text] [Related]
32. Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.
Lauten M; Möricke A; Beier R; Zimmermann M; Stanulla M; Meissner B; Odenwald E; Attarbaschi A; Niemeyer C; Niggli F; Riehm H; Schrappe M
Haematologica; 2012 Jul; 97(7):1048-56. PubMed ID: 22271901
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological and immunophenotypic features of early T cell precursor acute lymphoblastic leukaemia: A flow cytometry score for the initial diagnosis.
Chandra D; Singh MK; Gupta R; Rahman K; Yadav DD; Sarkar MK; Gupta A; Yadav S; Kashyap R; Nityanand S
Int J Lab Hematol; 2021 Dec; 43(6):1417-1423. PubMed ID: 34115925
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
Maude SL; Dolai S; Delgado-Martin C; Vincent T; Robbins A; Selvanathan A; Ryan T; Hall J; Wood AC; Tasian SK; Hunger SP; Loh ML; Mullighan CG; Wood BL; Hermiston ML; Grupp SA; Lock RB; Teachey DT
Blood; 2015 Mar; 125(11):1759-67. PubMed ID: 25645356
[TBL] [Abstract][Full Text] [Related]
35. [Lineage switch from T-lymphoblastic leukemia to myeloid leukemia at relapse].
Kuze A; Ida N; Hosono N; Negoro E; Yamauchi T
Rinsho Ketsueki; 2021; 62(7):721-726. PubMed ID: 34349054
[TBL] [Abstract][Full Text] [Related]
36. [Immunophenotypic Analysis of Patients with Adult Acute T-Lymphoblastic Leukemia].
Lin N; Liu ZH; Wang PP; Fu W; Yan XJ; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):442-445. PubMed ID: 32319376
[TBL] [Abstract][Full Text] [Related]
37. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
Khogeer H; Rahman H; Jain N; Angelova EA; Yang H; Quesada A; Ok CY; Sui D; Wei P; Al Fattani A; Pierce S; Loghavi S; Lamb A; Hu P; Thakral B; Kanagal-Shamanna R; Jorgensen JL; Jabbour EJ; Kantarjian HM; Medeiros LJ; Khoury JD
Br J Haematol; 2019 Aug; 186(4):538-548. PubMed ID: 31115909
[TBL] [Abstract][Full Text] [Related]
38. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
[TBL] [Abstract][Full Text] [Related]
39. Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children.
Matherly LH; Taub JW; Wong SC; Simpson PM; Ekizian R; Buck S; Williamson M; Amylon M; Pullen J; Camitta B; Ravindranath Y
Blood; 1997 Jul; 90(2):578-89. PubMed ID: 9226157
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia.
Zhang Y; Qian JJ; Zhou YL; Huang X; Li JH; Li XY; Li CY; Wang HP; Lou YJ; Meng HT; Yu WJ; Tong HY; Jin J; Zhu HH
Front Oncol; 2020; 10():1423. PubMed ID: 32974153
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]